GlassScriptPhysician profile
Cory Jensen
NPI 1417516279
$3,455.56
in general payments reported to CMS, 2019-2025
15 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.62 · 2021: $99.31 · 2022: $331 · 2023: $784 · 2024: $1,042 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,939.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $780.13 | 2019-2025 | Cequa |
| Abbvie INC. | $547.66 | 2022-2025 | |
| Alcon Vision LLC | $535.76 | 2022-2025 | Clareon, Tryptyr, Rocklatan |
| Bausch & Lomb Americas INC. | $360.87 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Dompe US, INC. | $346.94 | 2024-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $226.92 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $211.89 | 2025 | |
| Mallinckrodt Hospital Products INC. | $126.95 | 2025 | Acthar |
| Coopervision INC. | $122.26 | 2024 | Myday Contact Lens |
| Glaxosmithkline, LLC. | $67.40 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $31.91 | 2021 | |
| Allergan, INC. | $27.33 | 2022 | |
| Lkc Technologies, INC. | $25.77 | 2024 | |
| Glaukos Corporation | $22.99 | 2023-2024 | Istent Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Johnson & Johnson Vision Care, INC. | $20.78 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.